| 4.59 0.25 (5.76%) | 10-29 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.69 |
1-year : | 6.65 |
| Resists | First : | 4.88 |
Second : | 5.69 |
| Pivot price | 4.39  |
|||
| Supports | First : | 4.36 |
Second : | 4.03 |
| MAs | MA(5) : | 4.4 |
MA(20) : | 4.42 |
| MA(100) : | 4.59 |
MA(250) : | 4.56 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 45.5 |
D(3) : | 33.7 |
| RSI | RSI(14): 58.2 |
|||
| 52-week | High : | 6.15 | Low : | 3.54 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ POCI ] has closed below upper band by 10.7%. Bollinger Bands are 26.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.6 - 4.61 | 4.61 - 4.63 |
| Low: | 4.32 - 4.34 | 4.34 - 4.36 |
| Close: | 4.55 - 4.59 | 4.59 - 4.62 |
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.
Tue, 27 Oct 2026
CEO pay of $381K is part of the advisory executive pay vote at Precision Optics (POCI). - Stock Titan
Fri, 23 Oct 2026
Precision Optics Corporation, Inc. Estimates – NASDAQ:POCI - TradingView
Tue, 29 Sep 2026
Precision Optics Corporation Q4 2026: Revenue Jumps 42% — Deep Dive - AlphaStreet
Tue, 29 Sep 2026
Precision Optics Corp Inc (POCI) (Q4 2026) Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
Mon, 28 Sep 2026
Precision Optics Corp Q4 2026 Earnings Call: Complete Transcript - Benzinga
Wed, 23 Sep 2026
Precision Optics Corporation Schedules Fourth Quarter and Full Year Fiscal 2026 Earnings Conference Call - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 11 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 19.8 (%) |
| Held by Institutions | 41.7 (%) |
| Shares Short | 40 (K) |
| Shares Short P.Month | 11 (K) |
| EPS | -0.44 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.86 |
| Profit Margin | -11.6 % |
| Operating Margin | -1.3 % |
| Return on Assets (ttm) | -8.5 % |
| Return on Equity (ttm) | -22.3 % |
| Qtrly Rev. Growth | 42 % |
| Gross Profit (p.s.) | 0.49 |
| Sales Per Share | 2.87 |
| EBITDA (p.s.) | -0.3 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -10.68 |
| PEG Ratio | 0 |
| Price to Book value | 2.46 |
| Price to Sales | 1.59 |
| Price to Cash Flow | -32.49 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|